Scientists scan muscles to see how SMA treatments really work
NCT ID NCT06532474
Summary
This study aims to learn how existing spinal muscular atrophy (SMA) medications affect patients' muscles and nerve cells over time. Researchers will observe 24 children and young adults (ages 5-20) with SMA types 2 and 3 who are already taking drugs like Spinraza, Zolgensma, or Evrysdi, or are untreated. The main goal is to test new scanning methods to measure muscle energy use and health during exercise, without giving any new treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL MUSCULAR ATROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Jude Children's Research Hospital
RECRUITINGMemphis, Tennessee, 38105, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.